Anthem Biosciences – Is it time to book profits?
Media Anthem Biosciences – Is it time to book profits?Anthem Biosciences Limited NSE:ANTHEM ChartTheWave Media
IPO Case study - Anthem Biosciences
Following a brief rally after listing, Anthem Biosciences underwent a correction lasting about 137 days, forming a Zigzag. Wave A was longer than Wave C, and the correction appears to have concluded on 2 February 2026. The stock subsequently began forming its first impulse wave.
It now appears highly likely that the first impulse has been completed.
Wave structure
Wave I – A small 5-wave sequence.
Wave II – A deep correction, retracing approximately 78.6% of Wave I.
Wave III – An extended 5-wave sequence, reaching approximately 1.618 × Wave I.
Wave IV – A relatively small Zigzag, retracing about 38.2% of Wave III.
Wave V – Another extended wave, which appears to have terminated around 78.6% of the combined length of Waves I–III.
The stock has delivered over 60% from its February lows, and the wave structure now suggests that the first impulse may have run its course.
It may therefore be prudent to book partial profits at current levels and consider adding to the position after the corrective phase is complete.
TradingView
Anthem Biosciences – Is it time to book profits? for NSE:ANTHEM by ChartTheWave
IPO Case study - Anthem Biosciences
Following a brief rally after listing, Anthem Biosciences underwent a correction lasting about 137 days, forming a Zigzag. Wave A was longer than Wave C, and the correction appears to have concluded on 2 February 2026.…
August 30, 2026 10
